T0	MultiCitation 3095 3116	Narendra et al., 2010
T1	Citation 10254 10275	Narendra et al., 2010
T2	MultiCitation 10644 10665	Narendra et al., 2010
T3	Citation 11420 11441	Narendra et al., 2010
T4	Citation 30393 30414	Narendra et al., 2010
T5	MultiCitation 32905 32909	2010
T6	Span 2890 3144	Consistent with genetic studies in flies that indicated that they work in the same pathway, Parkin translocation and mitophagy induction require PINK1 activity (Geisler et al., 2010; Matsuda et al., 2010; Narendra et al., 2010; Vives-Bauza et al., 2010).
R1	Context Target:T0 Context:T6	
T7	Span 10197 10276	ParkinC441R, which fails to translocate to mitochondria (Narendra et al., 2010)
R2	Context Target:T1 Context:T7	
T8	Span 10464 10693	In contrast to transient expression of wild-type YFP-Parkin, expression of neither YFP-ParkinR275W nor YFP-ParkinC441R induced Mfn1/2 elimination upon CCCP treatment (Fig. 2, e and f). PINK1, a mitochondrial kinase, is essential for the Parkin translocation to depolarized mitochondria and for Parkin-mediated mitophagy (Geisler et al., 2010; Matsuda et al., 2010; Narendra et al., 2010; Vives-Bauza et al., 2010).
R3	Context Target:T2 Context:T8	
T9	Span 11192 11443	In contrast to inhibition of transcription, inhibition of translation by treatment with cycloheximide (CHX) prevents both the CCCP-dependent induction of PINK1 expression and Parkin translocation to CCCP-uncoupled mitochondria (Narendra et al., 2010).
R4	Context Target:T3 Context:T9	
T10	Span 30318 30544	M17 neuroblastoma carrying small hairpin RNA (shRNA) for control or PINK1 (Narendra et al., 2010) were maintained with Opti-MEM, 10% heat-inactivated fetal calf serum (Gemini Bio-Products), and 10 Âµg/ml Blastidin (Invitrogen).
R5	Context Target:T4 Context:T10	
T11	Span 32701 32911	The plasmids carrying shRNA sequences for DRP1, Mito-YFP, mCherry-Parkin, YFP-Parkin (wild type, R275W, C441R), and Mfn2-YFP have been described previously (Karbowski et al., 2007; Narendra et al., 2008, 2010).
R6	Context Target:T5 Context:T11	
